Recently, Cardinali et al. have tested the effects of two new synthetic AhR agonists, NPD-0614-13 and NPD-0614-24, in human epidermal and full-thickness reconstituted skin models of psoriasis [88]. The gene discussed is AHR; the disease is psoriasis.